[Intensive therapy during splenectomy in patients with subleukemic myelosis].
On the basis of analysis of splenectomies in 25 patients in the terminal stage of subleukemic myelosis--myelofibrosis with the aim of prevention and treatment of complications and better endurability of splenectomy the authors have elaborated a complex of measures for intensive therapy such as conducting the operation under protection of donor thrombocytes, limited transfusion of the whole blood, early administration of antibiotics, heparin therapy and disaggregation therapy in postoperative therapy.
D000328:Adult; D000758:Anesthesia; D001803:Blood Transfusion; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005260:Female; D006487:Hemostasis; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000150:complications / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000209:etiology; D017713:Platelet Transfusion; D011183:Postoperative Complications; D011184:Postoperative Period; D011300:Preoperative Care; D055728:Primary Myelofibrosis / Q000097:blood / Q000150:complications / Q000601:surgery*; D013156:Splenectomy
Intensivnaia terapiia pri splenéktomii u bol'nykh subleĭkemicheskim mielozom.